How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3)

被引：138

作者：

Wijnen, B. F. M. ^{[1
,2
]}

Van Mastrigt, G. A. P. G. ^{[1
]}

Redekop, W. K. ^{[3
]}

Majoie, H. J. M. ^{[2
,4
,5
,7
,8
]}

De Kinderen, R. J. A. ^{[1
]}

Evers, S. M. A. A. ^{[1
,6
]}

机构：

[1] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Maastricht, Netherlands

[2] Epilepsy Ctr Kempenhaeghe, Dept Res & Dev, Heeze, Netherlands

[3] Erasmus Univ, Inst Med Technol Assessment, Dept Hlth Policy & Management, Rotterdam, Netherlands

[4] Epilepsy Ctr Kempenhaeghe, Acad Ctr Epileptol, Dept Neurol, Maastricht, Netherlands

[5] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[6] Netherlands Inst Mental Hlth & Addict, Dept Econ Evaluat, Utrecht, Netherlands

[7] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands

[8] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Hlth Profess Educ, Maastricht, Netherlands

来源：

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2016年 / 16卷 / 06期

关键词：

Systematic reviews; economic evaluations; clinical practice guidelines; risk of bias; quality appraisal; data-extraction; TECHNOLOGY ASSESSMENTS; QUALITY; GUIDELINES; MODEL; CRITERIA; TRIAL; TOOL;

D O I：

10.1080/14737167.2016.1246961

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Introduction: This article is part of the series How to Prepare a Systematic Review (SR) of Economic Evaluations (EE) for Informing Evidence-based Healthcare Decisions in which a five-step-approach for conducting a SR of EE is proposed.Areas covered: This paper explains the data extraction process, the risk of bias assessment and the transferability of EEs by means of a narrative review and expert opinion. SRs play a critical role in determining the comparative cost-effectiveness of healthcare interventions. It is important to determine the risk of bias and the transferability of an EE.Expert commentary: Over the past decade, several criteria lists have been developed. This article aims to provide recommendations on these criteria lists based on the thoroughness of development, feasibility, overall quality, recommendations of leading organizations, and widespread use.

引用

页码：723 / 732

页数：10

共 37 条

[1]

[Anonymous], EXPERT REV PHARMACOE

[2]

[Anonymous], PREPARE SYSTEMATIC 1

[3]

[Anonymous], PREPARE SYSTEMATIC R

[4]

[Anonymous], GRADING EC EVIDENCE

[5]

[Anonymous], 2009, CRD's guidance for undertaking reviews in health care

[6]

[Anonymous], EXPERT REV PHARMACOE

[7]

[Anonymous], 2015, METHODS EC EVALUATI

[8]

[Anonymous], EXCELLENCE N I F C D

[9] Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].

Begg, C ;

Cho, M ;

Eastwood, S ;

Horton, R ;

Moher, D ;

Olkin, I ;

Pitkin, R ;

Rennie, D ;

Schulz, KF ;

Simel, D ;

Stroup, DF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639

[10] AGREE II: advancing guideline development, reporting and evaluation in health care [J].

Brouwers, Melissa C. ;

Kho, Michelle E. ;

Browman, George P. ;

Burgers, Jako S. ;

Cluzeau, Francoise ;

Feder, Gene ;

Fervers, Beatrice ;

Graham, Ian D. ;

Grimshaw, Jeremy ;

Hanna, Steven E. ;

Littlejohns, Peter ;

Makarski, Julie ;

Zitzelsberger, Louise .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) :E839-E842

← 1 2 3 4 →